Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

New Study Finds Association Between Small Noncoding RNAs and Cancer

By BiotechDaily International staff writers
Posted on 06 Mar 2014
Print article
A team of Canadian molecular biologists has established a link between some types of small noncoding RNAs (smRNAs) and certain cancers.

SmRNAs—RNA molecules that do not give rise to proteins but which may have other important functions in the cell—have been shown to be significantly enriched near the transcriptional start sites of genes. However, the functional relevance of these smRNAs has remained unclear, and they have not been associated with human disease.

Now, in a groundbreaking study, investigators associated with The Cancer Genome Atlas Project (Bethesda, MD, USA) have found that differences in the levels of specific types of noncoding RNAs can be used to distinguish between cancerous and noncancerous tissues. The Cancer Genome Atlas Project is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing.

In prior cancer studies, these RNAs had been regarded as transcriptional "noise,” due to their apparent chaotic distribution. In contrast, in a study published in the February 1, 2014, issue of the journal EMBO reports investigators at the University of British Columbia (Vancouver, Canada) demonstrated the striking potential of certain smRNAs to distinguish efficiently between cancer and normal tissues and classify patients with cancer to subgroups of distinct survival outcomes.

They stressed that this potential to predict cancer status was restricted to a subset of smRNAs, which was encoded within the first exon of genes, highly enriched within CpG islands and negatively correlated with DNA methylation levels. In a CpG island, both cytosine and the guanine are found on the same strand of DNA or RNA and are connected by a phosphodiester bond.

"For many years, small non-coding RNAs near transcriptional start sites have been regarded as "transcriptional noise" due to their apparent chaotic distribution and an inability to correlate these molecules with known functions or disease," said senior author Dr. Steven Jones, professor of molecular biology at the University of British Columbia. "By using a computational approach to analyze small RNA sequence information that we generated as part of The Cancer Genome Atlas Project, we have been able to filter through this noise to find clinically useful information."

"The data from our experiments show that genome-wide changes in the expression levels of small noncoding RNAs in the first exons of protein-coding genes are associated with breast cancer," said Dr. Jones. "This is the first time that small noncoding RNAs near the transcription start site of genes have been associated with disease. Further work is required but based on our data we believe there is considerable diagnostic potential for these small noncoding RNAs as a predictive tool for cancer. In addition, they may help us understand better the mechanisms underlying oncogenesis at the epigenetic level and lead to potential new drugs employing small noncoding RNAs."

Related Links:

The Cancer Genome Atlas Project
University of British Columbia



Print article

Channels

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.